Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1057 of 1,261
  1. US 7388088

    High affinity human antibodies to tumor antigens

    The Regents of the University of California · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  2. US 7388074

    Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  3. US 7388017

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  4. US 7388002

    Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

    BioCryst Pharmaceuticals, Inc. · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  5. US 7387881

    Detection and treatment of cancers of the liver

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  6. US 7388071

    Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response

    The Regents of the University of California · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  7. US 7387896

    MicroRNA vectors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  8. US 7388089

    Anti-arthropod vector vaccines method of selecting and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  9. US 7384909

    Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted
  10. US 7384921

    Polymorphic forms of 6-11 bicyclic ketolide derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted
  11. US 7384623

    High energy phototherapeutic agents

    Provectus Pharmatech, Inc. · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted
  12. US 7384978

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted
  13. EP 1926473

    ANTIMIKROBIELLE ZUBEREITUNGEN MIT EINEM IN LIPOSOMEN VERKAPSELTEN GEHALT AN OCTENIDINDIHYDROCHLORID

    AIR LIQUIDE SANTE INT [FR] · Granted Jun 4, 2008 · Expires May 30, 2028

    granted
  14. US 7381825

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  15. US 7381699

    Reagents and methods for smooth muscle therapies

    THE ARIZONA BOARD OF REGENTS · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  16. US 7381827

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  17. US 7381748

    Compounds and related methods for inhibition of gamma-aminobutyric acid aminotransferase

    Northwestern University · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  18. US 7381408

    Methods for chemically synthesizing immunoglobulin chimeric proteins

    Syntonix Pharmaceuticals, Inc. · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  19. US 7381405

    Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  20. US 7381744

    Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  21. US 7381404

    Treatment for dry macular degeneration

    The Regents of the University of California · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  22. US 7378273

    Expression vectors

    Gala Design, Inc. · Granted May 27, 2008 · Expires May 22, 2028

    granted
  23. US 7378251

    Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein

    Rigel Pharmaceuticals, Inc. · Granted May 27, 2008 · Expires May 22, 2028

    granted
  24. US 7378422

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted May 27, 2008 · Expires May 22, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.